001
ABOUT FUTURE
We are neither a traditional supplement company nor an academic institution.
We have combined the best of both without the limitations of either:
WE ARE AN RESEARCH LAB ON A MISSION TO RADICALLY ENHANCE HUMAN PERFORMANCE WITH THE MOST ADVANCED SUPPLEMENTS IN HISTORY. ///////////
Future was founded in silicon valley as a vehicle for exploring the very limits of human performance. With a background in organic chemistry and genetics, we blur the boundaries between biology and technology to develop the next generation of safe and legal supplements.
WE MAY NOT BE THE LARGEST OR MOST WELL-KNOWN, BUT WE DEVELOP SOME OF THE INDUSTRIES MOST EFFECTIVE SUPPLEMENTS. ///////////
WELCOME TO THE FUTURE
////////////
WELCOME TO THE FUTURE ////////////
002MISSION
Our mission is stated simply, yet it is quite ambitious: we are tackling one of the most challenging and fundamental biological mysteries of our time:
WHAT IS THE UNDERLYING CELLULAR BIOLOGY THAT DETERMINES AGING?
…and use the knowledge we gain to develop interventions that will redefine the limits of human potential.
003 
THE EXPERIMENT THAT STARTED IT ALL
Dr. Kenyon's Breakthrough at the University of California (UCSF) Doubles Lifespan, Proving Aging Can Be Biologically Hacked
Aging was once considered an inevitable process.
Cynthia Kenyon, PhD, now Vice President of Aging at Google's secret anti-aging biotech division, conducted a landmark study at the University of California, San Francisco (UCSF). Her research revealed that activation of the daf-2 molecular pathway doubled animal lifespans while enhancing their youth and vitality.
This groundbreaking work proved, for the first time, that aging and performance can be modulated at the molecular level.
Check out Cynthia’s paper in Nature titled, “A C. elegans mutant that lives twice as long as wild type.”
Geneticist Cynthia Kenyon, University of CaliforniaIMMORTALITY IS EVEN THEORETICALLY POSSIBLE /////////
WHY NOW?
Because we believe the human enhancement industry has reached a barrier beyond which it cannot further extend human performance with its current technologies:
004DISRUPTING THE STATUS QUO OF THE SUPPLEMENT INDUSTRY.
Landmark scientific discoveries over the past 20 years—from decoding the human genome to identifying cellular causes of aging—have unlocked solutions that redefine the limits of human performance.
In collaboration with the world’s leading scientists, Future is creating an entirely new category in the industry by translating anti-aging breakthroughs into genomic enhancement biotechnologies.
WE BELIEVE THIS IS AN ENTIRELY NEW APPROACH
TO HUMAN ENHANCEMENT /////////
005
Academic research is the driving force behind supplements. Future Pharma operates at the intersection of academic research, where discoveries for advanced supplements lie.
HARNESSING BREAKTHROUGHS FROM WORLD-LEADING INSTITUTIONS
////////// BLEEDING EDGE OF RESEARCH.
-
Researchers at Harvard Medical School, led by Dr. David Sinclair, uncovered the SIRT molecular pathway—widely regarded as the elusive root cause of aging.
-
// The Pentagon's DARPA (Defense Advanced Research Projects Agency), the research arm of the U.S. military, is conducting an elite soldier project, 'Metabolic Dominance,' aimed at biochemically hacking metabolism to push the limits of human endurance.
Their breakthrough discovery, D-BHB, is a new form of energy that acts as a metabolic superfuel—revolutionizing energy production by enhancing mitochondrial efficiency and optimizing oxygen utilization at the cellular level.
Phase 1 of the study, conducted in collaboration with the U.S. Special Operations Command (USSOCOM), demonstrated a 15% improvement in mean power output among athletes following the BHB protocol during endurance training sessions.
McCarthy, Devin G et al. “Increased cardiorespiratory stress during submaximal cycling after ketone monoester ingestion in endurance-trained adults.” Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme vol. 46,8 (2021): 986-993. doi:10.1139/apnm-2020-09990
006WE ARE DIFFERENT BY DESIGN
Our focus is not on marketing existing nutritional products, but on the inception of next-generation technologies that deliver lasting value to the scientific community.
With human clinical trials completed, several patents granted, and showcased in international news, Future Pharma has designed and produced some of the most effective ergogenic aids in the industry—advancing longevity, musculoskeletal health, metabolic function, aerobic capacity, and cognitive enhancement.
///////// FEATURED ACROSS INTERNATIONAL MEDIA
HUMAN CLINICAL TRIALS
//Epicatechin (-)- Inhibits Catabolic Myostatin, Producing A 7% Strength Gain In 7 Days In A Mexican Instituto De Medicina Human Trial
FEATURED IN INTERNATIONAL PRESS
// "The Silicon Valley Startup hacking human Performance at the Molecular Level"
PATENTED SUPERIOR COMPOUNDS
// Molecularly modified HMB analog HICA, developed with Johns Hopkins University, produces 367% greater anti-catabolic effects compared to standard HMB.
008
Future traces its origins to the Santa Fe Institute for Complex Systems, the birthplace of 'complexity science'—a revolutionary field that unites once-disjointed disciplines such as nanotechnology, biotechnology, AI, and genomics to understand complex systems.
Founded in 1984 by renegade scientists frustrated by the confines of traditional research, we sought to push the boundaries of science by addressing its biggest unanswered questions—a spirit that continues to guide Future Pharmaceuticals today.
AT FUTURE PHARMACEUTICALS,
WE TACKLE THE COMPLEX AND MULTICAUSAL PROBLEM OF HUMAN PERFORMANCE WITH AN EQUALLY MULTIFACETED SOLUTION.
RADICAL TECHNOLOGY. RADICAL BIOPHARMA ///////////
GENOMICS
// Cracking The Genetic Source Code Of Life.
ARTIFICAL INTELLIGENCE
// Simulating complex biological ecosystems.
BIOTECHNOLOGY
// Engineering the biological fabric of life
NANOTECHNOLOGY:
// 100% Bioavailability Direct to Target Cell
ALL MADE POSSIBLE BY A COLLABORATION OF WORLD-LEADING SCIENTISTS.
As an interdisciplinary group, we can leverage a multi-factor approach to tackle the multi-factor problem of aging. Operating at the super-convergence of advanced technologies allows us to study cell metabolism as an integrated, interconnected system rather than isolated parts—something traditional reductionist biology is fundamentally incapable of.
009FOSTERING CULTURE OF DISRUPTIVE SCIENCE
By combining the resources and scientific pedigree of institutional academia with the disruptive mindset and cutting-edge technology of a startup, we foster breakthroughs that push the boundaries of possibility.
Free from the constraints of corporate bureaucracy and rigid scientific ideology, our skunkworks research lab encourages bold innovation, risk-taking experimentation, and unconventional thinking—surpassing the limitations of traditional medical research.
COMBINING OLD
ACADEMIA WITH NEW
TECHNOLOGY FOR TOMMOROW’S PHARMACEUTICALS
LEGENDARY MIT PROFESSOR CLAUD SHANNON /////////// "WE ADMIRE THE SKUNKWORKS MODEL OF BELL LABS. HIRE A LOT OF REALLY TALENTED PEOPLE, INSPIRE THEM WITH AN ASPIRATIONAL GOAL LIKE UNDERSTANDING AGING, PROVIDE THEM WITH RESOURCES AND ACCESS TO ADVANCED TECHNOLOGY, AND GIVE THEM THE FREEDOM TO COLLABORATE ON THINGS THEY ARE PASSIONATE ABOUT...AND INCREDIBLE THINGS CAN HAPPEN."
MIT AND BELL LABS PROFESSOR CLAUDE SHANNON’S QUANTUM BIOLOGY BREAKTHROUGH THAT INVENTED THE FUTURE.
Our work at Future is fundamentally underpinned by Claude Shannon’s revolutionary Information Theory, which redefined all life as a fundamentally information-based phenomenon. With this perspective, DNA becomes a code—the cell’s epigenetic operating system—that can be read and programmed like a computer.